Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-07

Clinical Trial Update: Remineralization Potential of Pearl Powder Compared to CPP-ACP on Enamel White Spot Lesions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating remineralization potential of pearl powder versus CPP-ACP on enamel white spot lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CPP-ACP (Casein phosphopeptide-amorphous calcium phosphate)
  • Pearl powder

Snippet

Sponsor: Cairo University | Conditions: White Spot Lesion | Phase 2 | Status: UNKNOWN